Welcome to LookChem.com Sign In|Join Free
  • or
(DES-PYR1)-LHRH is a synthetic form of luteinizing hormone-releasing hormone (LHRH) that is engineered to provide a longer-lasting effect than the natural LHRH. It is designed with a modified structure, des-glycinamide-lysine prostamide pyroglutamate, which enables sustained inhibition of luteinizing hormone and follicle-stimulating hormone release, thereby reducing testosterone production. This reduction in testosterone levels is crucial for the treatment of hormone-sensitive prostate cancer, as it helps slow the progression of the disease.
Used in Pharmaceutical Industry:
(DES-PYR1)-LHRH is used as a therapeutic agent for the treatment of hormone-sensitive prostate cancer. It is specifically utilized to lower testosterone levels in the body, which is essential in managing the progression of prostate cancer. The depot injection form of administration allows for a gradual release of the medication over an extended period, enhancing patient convenience and adherence to treatment.

38280-53-4

Post Buying Request

38280-53-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

38280-53-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 38280-53-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,8,2,8 and 0 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 38280-53:
(7*3)+(6*8)+(5*2)+(4*8)+(3*0)+(2*5)+(1*3)=124
124 % 10 = 4
So 38280-53-4 is a valid CAS Registry Number.
InChI:InChI=1/C50H70N16O11/c1-27(2)17-36(45(73)62-35(9-5-15-56-50(53)54)49(77)66-16-6-10-40(66)48(76)58-23-41(52)69)61-42(70)24-59-44(72)37(18-28-11-13-31(68)14-12-28)64-47(75)39(25-67)65-46(74)38(19-29-21-57-34-8-4-3-7-32(29)34)63-43(71)33(51)20-30-22-55-26-60-30/h3-4,7-8,11-14,21-22,26-27,33,35-40,57,67-68H,5-6,9-10,15-20,23-25,51H2,1-2H3,(H2,52,69)(H,55,60)(H,58,76)(H,59,72)(H,61,70)(H,62,73)(H,63,71)(H,64,75)(H,65,74)(H4,53,54,56)/t33-,35-,36-,37-,38-,39-,40-/m0/s1

38280-53-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name (Des-Pyr1)-LHRH

1.2 Other means of identification

Product number -
Other names gonadotropin releasing-hormone

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:38280-53-4 SDS

38280-53-4Downstream Products

38280-53-4Relevant academic research and scientific papers

Hydrolytic cleavage of pyroglutamyl-peptide Bond. V. Selective removal of pyroglutamic acid from biologically active pyroglutamylpeptides in high concentrations of aqueous methanesulfonic acid

Kobayashi, Junko,Ohki, Kazuhiro,Okimura, Keiko,Hashimoto, Tadashi,Sakura, Naoki

, p. 827 - 831 (2007/10/03)

Application of aqueous methanesulfonic acid (MSA) for selective chemical removal of pyroglutamic acid (pGlu) residue from five biologically active pyroglutamyl-peptides (pGlu-X-peptides, X=amino acid residue at position 2) was examined. Gonadotropin releasing hormone (Gn-RH), dog neuromedin U-8 (d-NMU-8), physalaemin (PH), a bradykinin potentiating peptide (BPP-5a) and neurotensin (NT) as pGlu-X-peptides were incubated in either 70% or 90% aqueous MSA at 25°C. HPLC analysis of the incubation solutions showed that the main decomposition product was H-X-peptide derived from each pGlu-X-peptide by the removal of pGlu. The results revealed that the pGlu-X peptide bond had higher susceptibility than various internal amide bonds in the five peptides examined, including the Trp-Ser bond in Gn-RH, the C-terminal Asn-NH2 in d-NMU-8, and the Asp-Pro bond in PH, whose acid susceptibility is well known. Thus, mild hydrolysis with high concentrations of aqueous MSA may be applicable to chemically selective removal of pGlu from pGlu-X-peptides for structural examinations.

Characterization of the degradation products of luteinizing hormone releasing hormone

Motto,Hamburg,Graden,Shaw,Cotter

, p. 419 - 423 (2007/10/02)

The degradation products of luteinizing hormone releasing hormone [LH/RH; 1; gonadorelin releasing hormone (GnRH); 2] were determined in aqueous solution (pH 6.5) at 25, 37, 50, and 80 °C. The predominant route of degradation involved the cleavage of the 2 to the free acid form in peptides 4 and 10. Racemization of the serine and histidine residues to give peptides 2 and 3 was a second route of degradation.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 38280-53-4